Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Balwani

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Neurology|May 5, 2026
Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher RegistryRoy N Alcalay, Pramod Mistry, Alessio Di Fonzo, et al.
Molecular Genetics and Metabolism|January 1, 2022
Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensusPriya S Kishnani, Walla Al-Hertani, Manisha Balwani, et al.
JIMD Reports|January 21, 2021
Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trialsElena Lukina, Manisha Balwani, Nadia Belmatoug, et al.
The New England Journal of Medicine|April 12, 2023
Dersimelagon in Erythropoietic ProtoporphyriasManisha Balwani, Herbert L Bonkovsky, Cynthia Levy, et al.
Hepatology (Baltimore, Md.)|June 13, 2017
Acute hepatic porphyrias: Recommendations for evaluation and long-term managementManisha Balwani, Bruce Wang, Karl E Anderson, et al.
Molecular Genetics and Metabolism Reports|November 21, 2022
A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyriaManisha Balwani, Hetanshi Naik, Jessica R Overbey, et al.
Journal of the American Academy of Dermatology|December 13, 2025
Bitopertin shows efficacy in patients with erythropoietic protoporphyria: Results from the randomized, double-blind, placebo-controlled AURORA trialAmy K Yeung, Herbert L Bonkovsky, Manisha Balwani, et al.
Molecular Genetics and Metabolism|November 5, 2018
Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyriaJohn Phillips, Collin Farrell, Yongming Wang, et al.
Human Mutation|August 20, 2016
Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant DiseaseBrenden Chen, Constanza Solis-Villa, Jörg Hakenberg, et al.
Blood Cells, Molecules & Diseases|November 12, 2010
The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher RegistryBarry Rosenbloom, Manisha Balwani, Jeff M Bronstein, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Neurology|May 5, 2026
Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher RegistryRoy N Alcalay, Pramod Mistry, Alessio Di Fonzo, et al.
Molecular Genetics and Metabolism|January 1, 2022
Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensusPriya S Kishnani, Walla Al-Hertani, Manisha Balwani, et al.
JIMD Reports|January 21, 2021
Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trialsElena Lukina, Manisha Balwani, Nadia Belmatoug, et al.
The New England Journal of Medicine|April 12, 2023
Dersimelagon in Erythropoietic ProtoporphyriasManisha Balwani, Herbert L Bonkovsky, Cynthia Levy, et al.
Hepatology (Baltimore, Md.)|June 13, 2017
Acute hepatic porphyrias: Recommendations for evaluation and long-term managementManisha Balwani, Bruce Wang, Karl E Anderson, et al.
Molecular Genetics and Metabolism Reports|November 21, 2022
A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyriaManisha Balwani, Hetanshi Naik, Jessica R Overbey, et al.
Journal of the American Academy of Dermatology|December 13, 2025
Bitopertin shows efficacy in patients with erythropoietic protoporphyria: Results from the randomized, double-blind, placebo-controlled AURORA trialAmy K Yeung, Herbert L Bonkovsky, Manisha Balwani, et al.
Molecular Genetics and Metabolism|November 5, 2018
Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyriaJohn Phillips, Collin Farrell, Yongming Wang, et al.
Human Mutation|August 20, 2016
Acute Intermittent Porphyria: Predicted Pathogenicity of HMBS Variants Indicates Extremely Low Penetrance of the Autosomal Dominant DiseaseBrenden Chen, Constanza Solis-Villa, Jörg Hakenberg, et al.
Blood Cells, Molecules & Diseases|November 12, 2010
The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher RegistryBarry Rosenbloom, Manisha Balwani, Jeff M Bronstein, et al.
Pageof 10